Omri Cohen, MD

Senior physician
Sheba medical center, Tel Aviv University
Holon, HaMerkaz, Israel

Dr. Omri Cohen MD, National Hemophilia Center and Institue of Thrombosis & Hemostasis, Sheba Medical Center, Israel

Dr. Omri Cohen received his MD from Ben Gurion University, Israel.
He specialized in both Internal Medicine and Hematology at the Tel Aviv Sourasky Medical Center affiliated with Tel Aviv University, Israel, completed a clinical fellowship in thrombosis and hemostasis at Sheba Medical Center, and a research fellowship at the Research Center on Thromboembolic Disease and Antithrombotic Therapies in Varese, Italy.
He currently leads the service for patients with unusual site thromboses at Sheba Medical Center.
His research projects focus on characterization, prevention and treatment of rare forms of venous thrombosis, thromboembolic diseases in adolescents and young adults, and peri-operative management of patients with hemophilia and rare bleeding disorders.

Presentation(s):

• PB0020 - Anticoagulation discharge treatment recommendations in patients admitted with a first-time diagnosis of atrial fibrillation

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB0473 - VTE outcomes in patients treated with direct oral anticoagulants and concurrent antiepileptic drugs: Data from the START2 and the RIETE

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• OC 43.5 - Should immune tolerance be pursued in the era of Emicizumab? Longitudinal follow up of a FVIII inhibitor cohort - Real World Data

  Monday, June 26, 2023
  15:45 – 16:00 ET

• PB0627 - Management of invasive procedures in patients with Hemophilia A receiving Emicizumab prophylaxis: Real-world data from a national Hemophilia treatment center.

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB1390 - Gray platelet syndrome- novel NBEAL2 pathogenic variants and hemostasis evaluation by global coagulation assays.

  Tuesday, June 27, 2023
  18:30 – 19:30 ET